BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 6421984)

  • 1. Clonal heterogeneity in the requirement for T3, T4, and T8 molecules in human cytolytic T lymphocyte function.
    Moretta A; Pantaleo G; Mingari MC; Moretta L; Cerottini JC
    J Exp Med; 1984 Mar; 159(3):921-34. PubMed ID: 6421984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for a regulatory role of the T8 (CD8) antigen in antigen-specific and anti-T3-(CD3)-induced lytic activity of allospecific cytotoxic T lymphocyte clones.
    Van Seventer GA; Van Lier RA; Spits H; Ivanyi P; Melief CJ
    Eur J Immunol; 1986 Nov; 16(11):1363-71. PubMed ID: 2430810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
    de Vries JE; Spits H
    J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of T3 and T8 molecules in human T cell receptor function. Anti-T3 or anti-T8 antibodies do not block the antigen-dependent activation of a subset of alloreactive cytolytic T cell precursors.
    Moretta A; Pantaleo G; Mingari MC; Moretta L
    Eur J Immunol; 1985 Aug; 15(8):803-8. PubMed ID: 3161744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical and functional association of the T cell receptor and the T3 molecular complex on cytotoxic T cell clones that are differentially inhibitable by anti-T3 antibodies.
    Leontsini E; Brown T; Biddison WE
    Cell Immunol; 1986 Oct; 102(1):21-32. PubMed ID: 2948659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonal analysis of the involvement of T11 molecules in antigen receptor-mediated T lymphocyte functions.
    Moretta A; Pantaleo G; Lopez-Botet M; Carrel S; Moretta L
    Behring Inst Mitt; 1985 Aug; (77):39-47. PubMed ID: 2417584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of monoclonal antibodies against cell surface molecules associated with cytotoxic activity of natural and activated killer cells and cloned CTL lines.
    Spits H; Keizer G; Borst J; Terhorst C; Hekman A; de Vries JE
    Hybridoma; 1983; 2(4):423-37. PubMed ID: 6332061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human T cell clones exerting multiple cytolytic activities show heterogeneity in susceptibility to inhibition by monoclonal antibodies.
    van de Griend RJ; Giphart MJ; Van Krimpen BA; Bolhuis RL
    J Immunol; 1984 Sep; 133(3):1222-9. PubMed ID: 6205072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility of cytotoxic T lymphocyte (CTL) clones to inhibition by anti-T3 and anti-T4 (but not anti-LFA-1) monoclonal antibodies varies with the "avidity" of CTL-target interaction.
    Shaw S; Goldstein G; Springer TA; Biddison WE
    J Immunol; 1985 May; 134(5):3019-26. PubMed ID: 2580011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T3 monoclonal antibody activation of nonspecific cytolysis: a mechanism of CTL inhibition.
    Mentzer SJ; Barbosa JA; Burakoff SJ
    J Immunol; 1985 Jul; 135(1):34-8. PubMed ID: 2582036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of T11 molecules in antigen receptor-mediated T lymphocyte functions: effect of anti-T11 monoclonal antibody on functional capabilities of alloreactive T cell clones.
    Moretta A; Pantaleo G; Lopez-Botet M; Mingari MC; Carrel S; Moretta L
    Eur J Immunol; 1985 Aug; 15(8):841-4. PubMed ID: 3161746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of autoreactive cytolytic T lymphocyte clone against human melanoma by anti-T3 monoclonal antibody and autologous accessory cells.
    Tatake RJ; Guha A; Mukherji B
    Cell Immunol; 1987 Aug; 108(1):42-52. PubMed ID: 3111724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapidly expanded activated human killer cell clones have strong antitumor cell activity and have the surface phenotype of either T gamma, T-non-gamma, or null cells.
    van de Griend RJ; van Krimpen BA; Ronteltap CP; Bolhuis RL
    J Immunol; 1984 Jun; 132(6):3185-91. PubMed ID: 6233369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal heterogeneity in the functional requirement for Lyt-2/3 molecules on cytolytic T lymphocytes: analysis by antibody blocking and selective trypsinization.
    MacDonald HR; Glasebrook AL; Cerottini JC
    J Exp Med; 1982 Dec; 156(6):1711-22. PubMed ID: 6983559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonal analysis of cytotoxic T lymphocytes (CTL) against autologous melanoma. Classification based on phenotype, specificity and inhibition by monoclonal antibodies to T cell structures.
    Hersey P; MacDonald M; Schibeci S; Burns C
    Cancer Immunol Immunother; 1986; 22(1):15-23. PubMed ID: 2423240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
    Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
    J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible involvement of the T4 molecule in T cell recognition of class II HLA antigens. Evidence from studies of CTL-target cell binding.
    Biddison WE; Rao PE; Talle MA; Goldstein G; Shaw S
    J Exp Med; 1984 Mar; 159(3):783-97. PubMed ID: 6199452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of human T lymphocytes. III. Triggering of bystander cytotoxicity in cytotoxic T cell clones by antibodies against the T3 antigen or by a calcium ionophore.
    Schrezenmeier H; Kurrle R; Wagner H; Fleischer B
    Eur J Immunol; 1985 Oct; 15(10):1019-24. PubMed ID: 3932080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Function of the CD4 and CD8 molecules on human cytotoxic T lymphocytes: regulation of T cell triggering.
    Fleischer B; Schrezenmeier H; Wagner H
    J Immunol; 1986 Mar; 136(5):1625-8. PubMed ID: 2419409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency and surface phenotype of human T lymphocytes producing interleukin 2. Analysis by limiting dilution and cell cloning.
    Moretta A
    Eur J Immunol; 1985 Feb; 15(2):148-55. PubMed ID: 3871697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.